A twenty-two-year-old who drinks heavily on weekends and a fifty-eight-year-old who has been drinking daily for three decades can both be given the same diagnosis, and both can be handed the same worksheet in the same group room. Their brains are not in the same condition, and a study published October 12 in Nature Health shows how different they are.
What the Nature Health study measured
Runye Shi, Shitong Xiang, Jianfeng Feng, and colleagues pooled brain scans from several large population cohorts, including ABCD, IMAGEN, the Human Connectome Project, and the UK Biobank. The discovery sample held 53,199 scans from 51,467 people aged 9 to 70, and a separate validation sample added 2,127 people aged 12 to 89. About 7,000 of the discovery participants met the study's definition of problematic substance use, which was based mostly on self-reported use of alcohol, tobacco, and cannabis. The remaining participants served as healthy controls.
The authors found that the structural brain differences linked to problematic substance use change with age, and they divided the pattern into three stages. They did not find a single "addicted brain" that looks the same at every age.
Before age 25: reward circuits ahead of the brakes
In people under about 25, problematic use was associated with a larger putamen and smaller volumes in the nucleus accumbens, insula, orbitofrontal cortex, and anterior cingulate. In plain terms, the circuits that pull toward reward were relatively built up while the circuits that hold behavior in check were relatively thin. Participants in this group also scored higher on sensation-seeking and rule-breaking, and in the ABCD cohort rule-breaking statistically mediated the link between brain structure and substance use.
The scans cannot tell us whether the differences came before the substance use or followed it, because most of the data are cross-sectional. What they do show is that a teenager who is using heavily is often a teenager whose impulse-control system is still under construction, which supports treating adolescent use as a medical problem.
Ages 25 to 45: the craving network gets larger
In the middle stretch the picture reverses. The insula, rostral anterior cingulate, and part of the orbitofrontal cortex were larger in people with problematic use, with the difference building from about age 30 and peaking in the mid-40s. These regions belong to the salience network, which decides what in your environment deserves your attention, and a cue that has been paired with a drug is the kind of thing an enlarged salience network keeps flagging as important.
The authors also reported that a dopamine-related factor, built from markers of dopamine synthesis, the dopamine transporter, and D1 and NMDA receptors, best explained the cortical differences, with the strongest effect around age 34. They tied one genetic signal in this stage to SUCLA2, a gene involved in mitochondrial energy metabolism. That finding is modest in size, but it fits with what we see clinically in this age group, where craving tends to persist long after the person has stopped using and decided that they want to stop.
After 45: cumulative loss
After about 45, the direction changes again. Volumes in the amygdala, hippocampus, nucleus accumbens, and medial orbitofrontal cortex were lower and declined faster in people with problematic use. The authors suggest cumulative toxicity and oxidative stress as the likely explanation, and a third gene signal, COA8, relates to mitochondrial function and protection against oxidative stress. This is also the stage where cognitive scores and inhibitory control were weakest.
Sex mattered too, mostly early in life and again after midlife. Females showed larger early-adulthood differences in the right nucleus accumbens and right insula, while males showed more in the dorsal striatum, and the later-life hippocampal losses were greater in females.
What this means for treatment and recovery
The practical implication is that one program cannot serve all three groups well. A 20-year-old needs treatment that builds the prefrontal and cingulate systems that are still developing, and that means structure, sleep, exercise, and cognitive training alongside counseling. A 38-year-old with an enlarged salience network benefits from work on cue exposure and craving management, and from a medical look at dopamine signaling and mitochondrial energy supply. A 55-year-old needs a cognitive and neuroimaging workup that finds out how much hippocampal and frontal reserve is left, because that determines what he can realistically do with a standard relapse-prevention curriculum.
The authors list real limits. Each age range came mostly from a single cohort, so some age effects may be cohort effects. Most of the trajectories came from cross-sectional data, and compulsivity was never measured directly. The samples were predominantly of European ancestry, and the drug-use subgroups were small. These findings describe populations and not individual patients, so they should shape the questions we ask, and they should not be used to predict any one person's course.
At The Neurogenesis Project we start from the premise that a person's brain state should determine the treatment, which is why Rescue From Rehab begins with imaging, biomarkers, and cognitive testing before a single protocol is chosen. Brain nutrition belongs in that conversation as well, and Action Potential Supplements is where we point patients who ask about it. If you or someone you love has been through a program that treated everyone the same way, the program was probably built for a different brain than yours.
This study gives us a map of where the damage, and the vulnerability, sit at different ages. The biology above is one more reason to stop treating heavy use as a character flaw. The goal of recovery is to match the treatment to the brain that is actually in the room.
This article was drafted with the assistance of AI writing tools, then reviewed, edited, and approved by Dr. Drew W. Edwards, Ed.D., who holds full editorial responsibility for its content.
Source: Shi R, Xiang S, et al. "Behavioural and brain volumetric changes associated with problematic substance use through the lifespan." Nature Health, October 12, 2026. doi:10.1038/s44360-026-00204-z.
